2023 | | Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection | 우현구 |
2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
2019 | | Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis | 권소미, 우현구, 윤사라, 지별아, 최지혜 |
2022 | | Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer | 강석윤 |
2013 | | Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. | 강호철, 백은주, 우현구, 이수환, 최용준 |
2021 | | High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer | 고영화 |
2018 | | Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer | 김영배, 우현구, 이다근, 최지혜, 한상욱 |
2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
2014 | | Identification of the rare compound heterozygous variants in the NEB gene in a Korean family with intellectual disability, epilepsy and early-childhood-onset generalized muscle weakness. | 이기영, 임신영, 정선용 |
2017 | | Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer | 우현구, 윤사라, 지별아, 최지혜 |